About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Swiss Drug Maker May Formulate Drugs for Alzheimer's After Results from Competitor

by Julia Samuel on April 24, 2015 at 11:31 AM
Font : A-A+

Swiss Drug Maker May Formulate Drugs for Alzheimer's After Results from Competitor

Roche, the Swiss drug maker is optimistic about formulating drugs for Alzheimer's disease after it received promising results with a similar product from Biogen, a competitor.

Daniel O'Day, Pharmaceuticals head, said that Roche would look again at prospects for two of its experimental Alzheimer's drugs, which suffered setbacks in 2014, in the wake of recent data on Biogen's drug.

Advertisement

Alzheimer's medicine, aducanumab in a small trial showed a significantly slowed cognitive impairment in patients with mild symptoms, which is a rare bit of good news in the midst of high-profile failures from the likes of Pfizer and Eli Lilly.

Aducanumab similar to Roche's experimental product gantenerumab, blocks beta amyloid, a protein that forms toxic brain plaques, the underlying cause of Alzheimer's. Yet the results presented in Biogen's trial contrasts with a late-stage Phase III study with gantenerumab and Roche's Phase II drug crenezumab.
Advertisement

"We're not at a stage where we've made a final decision on those two programs, but we're encouraged because the data that was presented from Biogen showed a concordance between dose level, between plaque removal and between clinical effect," said O'Day.

Current drugs prescribed for Alzheimer's can do no more than ease some of the symptoms rather than delaying the progression of Alzheimer's unlike heart disease and cancer, which have seen major strides in drug development.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Can Adjusting Fatty Acid Intake Improve Mood in Bipolar Disorder Patients?
Insulin Resistance Doubles the Risk of Major Depressive Disorder
Emotional Healing
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Alzheimers Disease Drug Toxicity Signature Drug Toxicity Drugs Banned in India Genetics of Alzheimer´s disease 

Recommended Reading
Donepezil may be Useful in Moderate-to-Severe Alzheimer’s Disease
Donepezil, which is currently used in mild-to-moderate cases of Alzheimer's disease, may be useful ....
Diet and Alzheimer´s Disease
Alzheimer''s begins with forgetfulness, but over time affects speech and coordination along with ......
Music Therapy at Kalamazoo Alzheimer’s Facility Makes Patients Smile, Think Better
Residents gather in the dining room, sing songs, play instruments and get to know each other ......
Antibodies That can Help Effectively Treat Alzheimer’s Disease Identified
A new study reports on the development of antibody treatments that can prevent the accumulation of ....
Alzheimers Disease
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and mak...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Drugs Banned in India
Several drugs are either banned or withdrawn after introduction in the market....
Genetics of Alzheimer´s disease
There are numerous genes that have been discovered that are associated with Alzheimer’s disease and ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use